Envestnet Asset Management’s Milestone Pharmaceuticals MIST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-63,742
| Closed | -$150K | – | 4427 |
|
|
2024
Q4 | $150K | Sell |
63,742
-6,848
| -10% | -$16.2K | ﹤0.01% | 4150 |
|
|
2024
Q3 | $107K | Buy |
70,590
+11,067
| +19% | +$16.8K | ﹤0.01% | 4131 |
|
|
2024
Q2 | $78.6K | Buy |
59,523
+7,690
| +15% | +$10.2K | ﹤0.01% | 4079 |
|
|
2024
Q1 | $92.8K | Buy |
51,833
+31,163
| +151% | +$55.8K | ﹤0.01% | 4066 |
|
|
2023
Q4 | $34.5K | Buy |
20,670
+1,696
| +9% | +$2.83K | ﹤0.01% | 4003 |
|
|
2023
Q3 | $58.8K | Buy |
18,974
+918
| +5% | +$2.85K | ﹤0.01% | 3927 |
|
|
2023
Q2 | $51.5K | Buy |
18,056
+1,626
| +10% | +$4.63K | ﹤0.01% | 3868 |
|
|
2023
Q1 | $64.7K | Buy |
16,430
+2,311
| +16% | +$9.11K | ﹤0.01% | 3832 |
|
|
2022
Q4 | $55.9K | Buy |
+14,119
| New | +$55.9K | ﹤0.01% | 3859 |
|